CUMBERLAND PHARMACEUTICALS INC (CPIX)
Pharmaceutical Preparations
Latest Price
$6.68
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.45
P/B Ratio
4.62
Valuation metrics
adjust assumptions →Base FCF: $6M (median of recent 5yr)
Growth: 22%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$24.28
+264% upside
Institutional Ownership
18.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 553.2K | $1.0M | 3.69% | -2.8K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 470.7K | $1.0M | 3.14% | -1.5K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 361.8K | $1.0M | 2.41% | -- | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 276.4K | -- | 1.84% | +4.1K | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 197.0K | -- | 1.31% | -144.1K | 2026-03-31 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 163.5K | -- | 1.09% | -- | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 127.7K | -- | 0.85% | -813 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 114.3K | -- | 0.76% | +7.0K | 2026-03-31 |
| J. Goldman & Co LP | 81.0K | -- | 0.54% | -13.5K | 2026-03-31 |
| JANE STREET GROUP, LLC | 58.9K | -- | 0.39% | +43.4K | 2026-03-31 |